Tonmya FDA Approval Status
FDA Approved: No
Brand name: Tonmya
Generic name: cyclobenzaprine hydrochloride
Previous Name: TNX-102
Company: Tonix Pharmaceuticals Holding Corp.
Treatment for: Post Traumatic Stress Disorder, Fibromyalgia
Tonmya (cyclobenzaprine) is a sublingual formulation of the approved skeletal muscle relaxant cyclobenzaprine in development for the treatment of patients with post-traumatic stress disorder (PTSD) and the management of fibromyalgia.
Development timeline for Tonmya
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.